The neointima formed in endothelial cell sodded ePTFE vascular grafts results from both cellular-hyperplasia and extracellular-hypertrophy.

Endothelial cell transplantation onto polymeric vascular grafts results in the formation of a neointima. The formation of this neointima is often suggested to result from a chronic cellular hyperplasia where the terms intimal hyperplasia and intimal thickening are used interchangeably. While the formation of a midgraft neointima in sodded grafts involves a level of cell proliferation, the synthesis and deposition of extracellular matrix proteins is also a ubiquitous observation in these grafts. To assess the composition of midgraft neointima in sodded grafts, a morphometric method was developed to provide a differential quantitation of the cellular-hyperplastic and extracellular-hypertrophic elements of intimal thickening. The formed neointima on microvessel endothelial cell sodded and control (noncell-treated) ePTFE vascular grafts was quantified after 3, 12, and 52 wk of graft implantation in a canine carotid artery model. Midgraft sections of grafts were evaluated for both intimal thickness (IT) and cell density per unit volume and quantified using a PC-based image analysis program. Sodded grafts explanted at 3 wk exhibited an average neointimal cell density (3 x 10(9) cells/cm3; IT 30 microns) equivalent to cell densities observed in normal arterial media. After 12 wk the mean cell density approached a hyperplastic value (3.7 x 10(9) cells/cm3; IT 76 microns), while grafts explanted after 52 wk exhibited a mean cell density (2.8 x 10(9) cells/cm3; IT 30 microns) similar to 3-wk values. Control grafts that received no cells exhibited no midgraft cellular coverage. These results indicate that neointima formation in the midgraft region of sodded grafts occurred via mechanisms involving both a cellular hyperplasia and an extracellular hypertrophy. Differential responses occur presumably due to localized differences in cellular proliferation and cellular biosynthetic activity.

[1]  M. Ferguson,et al.  Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. , 1993, Circulation research.

[2]  M. Sakon,et al.  Ultrastructural analysis of pseudo-intimal hyperplasia of polytetrafluoroethylene prostheses implanted into the venous and arterial systems. , 1992, European journal of vascular surgery.

[3]  S. Robbins,et al.  Pathologic basis of disease , 1974 .

[4]  W. Moore,et al.  An overview of intimal hyperplasia. , 1990, Surgery, gynecology & obstetrics.

[5]  S. Williams,et al.  Endothelial cell transplantation onto polymeric arteriovenous grafts evaluated using a canine model. , 1994, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[6]  S. Williams,et al.  Origin of endothelial cells that line expanded polytetrafluorethylene vascular grafts sodded with cells from microvascularized fat. , 1994, Journal of vascular surgery.

[7]  M. Tennant,et al.  Novel microsurgical model of experimental vascular neointimal hyperplasia , 1993, Microsurgery.

[8]  P. Fox,et al.  Increased platelet-derived growth factor production and intimal thickening during healing of Dacron grafts in a canine model. , 1993, Journal of vascular surgery.

[9]  T. Matsuda,et al.  An in vitro endothelialized compliant vascular graft minimizes anastomotic hyperplasia. , 1993, ASAIO journal.

[10]  A. Clowes,et al.  Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. , 1991, Circulation research.

[11]  Stuart K. Williams 8 Isolation and Culture of Microvessel and Large-Vessel Endothelial Cells: Their Use in Transport and Clinical Studies , 1987 .

[12]  A. Nicolaides,et al.  Graft stenosis: Justification for 1 ‐year surveillance , 1990, The British journal of surgery.

[13]  Paul F. McDonagh Microvascular perfusion and transport in health and disease , 1987 .

[14]  M. Reidy,et al.  Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia--a review. , 1991, Journal of vascular surgery.

[15]  Stuart K. Williams,et al.  Microvascular endothelial cell sodding of ePTFE vascular grafts: improved patency and stability of the cellular lining. , 1994, Journal of biomedical materials research.

[16]  M Tennant,et al.  A computerised morphometric technique for the analysis of intimal hyperplasia. , 1991, Journal of anatomy.

[17]  L. Hillis,et al.  Restenosis after successful coronary angioplasty. Pathophysiology and prevention. , 1988, The New England journal of medicine.

[18]  J. Stanley,et al.  The role of an endothelial cell lining in limiting distal anastomotic intimal hyperplasia of 4-mm-I.D. Dacron grafts in a canine model. , 1991, Journal of biomedical materials research.

[19]  S. Williams,et al.  Formation of a multilayer cellular lining on a polyurethane vascular graft following endothelial cell sodding. , 1992, Journal of biomedical materials research.

[20]  J. Rapp,et al.  Inhibition of injury induced intimal hyperplasia by saralasin in rats. , 1992, Journal of vascular surgery.

[21]  S. Schmidt,et al.  Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts. , 1993, Journal of vascular surgery.